Baseline gene expression patterns of CDK4/6 inhibitor-naïve or -refractory HR+, HER2-advanced breast cancer in the phase Ib study of ribociclib plus everolimus plus exemestane Meeting Abstract
| Authors: | Bardia, A.; Modi, S.; Cortes, J.; Campone, M.; Dirix, L.; Ma, B.; Beck, J. T.; Chaves, J.; Weise, A.; Vuky, J.; Lopes, G.; Gil-Gil, M.; Liu, X.; He, W.; Su, F.; Miller, M.; Chavez-MacGregor, M. |
| Abstract Title: | Baseline gene expression patterns of CDK4/6 inhibitor-naïve or -refractory HR+, HER2-advanced breast cancer in the phase Ib study of ribociclib plus everolimus plus exemestane |
| Meeting Title: | 109th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2018 Apr 14-18 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-07-01 |
| Language: | English |
| ACCESSION: | WOS:000468818900063 |
| DOI: | 10.1158/1538-7445.Am2018-ct069 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT069 -- Source: Wos |
